Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC cut its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 3.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 15,639 shares of the company’s stock after selling 546 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Henry Schein were worth $1,140,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Natixis Advisors LLC increased its holdings in shares of Henry Schein by 18.8% during the 3rd quarter. Natixis Advisors LLC now owns 81,877 shares of the company’s stock valued at $5,969,000 after purchasing an additional 12,930 shares in the last quarter. Simplify Asset Management Inc. increased its holdings in Henry Schein by 61.6% in the third quarter. Simplify Asset Management Inc. now owns 5,972 shares of the company’s stock valued at $435,000 after buying an additional 2,277 shares in the last quarter. CIBC Asset Management Inc increased its holdings in Henry Schein by 7.0% in the third quarter. CIBC Asset Management Inc now owns 17,680 shares of the company’s stock valued at $1,289,000 after buying an additional 1,162 shares in the last quarter. ING Groep NV acquired a new position in shares of Henry Schein in the third quarter worth about $63,226,000. Finally, Tokio Marine Asset Management Co. Ltd. purchased a new stake in shares of Henry Schein during the 3rd quarter worth about $301,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Insider Activity

In other news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. The trade was a 22.65 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on HSIC shares. Robert W. Baird reduced their price target on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. UBS Group dropped their price target on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. Evercore ISI upped their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Finally, Barrington Research reissued an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $78.89.

Henry Schein Trading Up 2.3 %

HSIC opened at $76.84 on Tuesday. The firm has a market capitalization of $9.58 billion, a price-to-earnings ratio of 31.62, a price-to-earnings-growth ratio of 2.15 and a beta of 0.87. The company’s 50 day simple moving average is $70.89 and its two-hundred day simple moving average is $69.73. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.63. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm’s revenue was up .4% compared to the same quarter last year. During the same quarter last year, the business posted $1.32 earnings per share. Analysts expect that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.